Tag:
taliglucerase alfa
Latest Headlines
Latest Headlines
Protalix showcases PhIII data for rare-disease drug in Pfizer pact
Amid its latest run for FDA approval of its Gaucher disease drug tied into a collaboration with Pfizer ( $PFE ), Protalix BioTherapeutics ( $PLX ) has published details from its Phase III package that
FDA hands Protalix a CRL for Gaucher's disease drug
The FDA has issued a complete response letter for Protalix's Gaucher's disease drug taliglucerase alfa. But the good news for Protalix is that the developer won't be required to conduct any
